The 10xHealth Program Modules
The intensive, 10-months program is inspired by the Moonshot approach by Astro Teller and comprises nine modules, where each module consists of a full day of lectures and workshops at Medicon Village followed by individually tailored follow-ups with participating companies.
The modules are led by experts in the respective fields, with the support of SmiLe Venture Hub and Medicon Village Innovation’s own experienced employees and coaches.
The ‘Moonshot Approach’
“Moonshot thinking is a mindset that challenges individuals to believe in achieving what initially seems impossible. It’s not literal, but rather an emotional blueprint to look beyond the visible and pursue seemingly unreasonable answers that could redefine humanity.”
– Lessons from X
Modules
The program consists of eight modules. Each module is led by experts in the respective fields, with the support of SmiLe Venture Hub and Medicon Village Innovation’s own experienced employees and coaches.
Module 1
Kicking off your Scale up journey
Led by Good Accelerator (Malin Jonsson & Kristian Engberg, and the 10xHealth team)
Date: 26 August 2025
Module 2
Strategy and business model innovation
Led by Lund University School of Economics and Management (Thomas Kalling and Craig Mitchell), Speaker: NanoEcho (Linda Persson)
Date: 18 September 2025
Module 3
People and governance
Led by SmiLe Venture Hub (Magnhild Owman ), Scaling Life Sciences (Martin Stenfeldt) and GBA Key2Compliance (Tomas Camnell)
Date: 21 October 2025
Module 4
Strategic finance and health economics for impact
Led by SmiLe Venture Hub (Thomas Unt and Åke Bengtsson), and SmartStep Nordics (Peter Hertzman)
Date: 20 November 2025
Module 5
Regulatory strategy and commercialisation
Led by GBA Key2Compliance (Jeanette Demorney & Tomas Camnell),
Scaling Life Sciences (Martin Stenfeldt),
Business Sweden (Jenny Strömberg & Georg Marthin)
Date: 27 January 2026
Module 6
Sustainability and storytelling for impact
Led by Albaeco (Louise Hård af Segerstad and Fredrik Moberg), and Chiaro (Giuseppe Marzio)
Date: 3 March 2026
Module 7
AI and cybersecurity for executives
Led by Secure By Q (Janne Karppinen and Petter Larsson), and Aistrateg Malmö (Dennis Westerberg)
Date: 16 April 2026
Module 8
Final countdown for growth
Led by Good Accelerator (Malin Jonsson and Kristian Engberg)
Date: 21 May 2026
Experts
New experts will be added in coming months
Good Accelerator
Good Accelerator is a platform that focuses on building successful businesses and organizations by harnessing the power of diverse individuals and spreading good leadership principles. They compare their philosophy to a cooperative school of fish where each individual contributes to maintaining course and adapting to changes without losing momentum.
Kristian Engberg, Associate Partner, Good Accelerator
Kristian has over 20 years of leadership experience from general and executive management positions, primarily in the global B2B building materials industry but also from growing SME in the building industry. As CEO, board member of various boards and private business owner, he has extensive experience in corporate governance, strategic business development and practical business management.
Malin Jonsson, Associate Partner, Good Accelerator
Malin brings 25 years of leadership experience in the telecommunications industry, including being part of the founding team of a mobile operator in Brazil that scaled from zero to one million customers in just three years. She has deep expertise in the commercial areas of product management, strategy, and sales. Malin also serves on the boards of both listed and privately held tech scale-up companies.
Lund University
Lund University, founded in 1666, stands among the world’s top universities with 45,000 students and 8,600 staff spread across Lund, Helsingborg, Malmö, and Ljungbyhed. Offering a diverse array of programs and courses, Lund fosters interdisciplinary collaboration, evident in its strong international partnerships spanning 75 countries.
Thomas Kalling,Professor of Strategy ,Lund University School of Economics and Management
Thomas Kalling is a Professor of Strategic Management at the Lund University School of Economics and Management. He has led research for the past 25 years in partnership with industry on strategic change, focusing on macro shifts such as deregulation, technology, digitalization, sustainability, globalization, and more. He has over 20 years of experience in executive education within strategic management and organization.
Craig Mitchell, Programme Director – Masters Programme in Entrepreneurship and Innovation at Lund University School of Economics and Management
Craig Mitchell is an entrepreneurship educator and lecturer at the Lund University School of Economics and Management. He is responsible for a leading Master’s Programme in Entrepreneurship and Innovation. With over 15 years’ experience teaching entrepreneurship and innovation, he has a passion for start-ups, scale-ups and corporate innovation. A self-confessed start-up geek currently teaching design thinking, business model innovation, business idea testing, value propositioning, pitch deck design and ideation.
Business Sweden
Business Sweden helps Swedish companies expand globally and supports international companies looking to invest and grow in Sweden. With a presence in the 50 most promising markets worldwide, they have been driving international business success for over 40 years.
For Swedish companies, Business Sweden provides strategic advice, sales execution, and operational support to accelerate global revenue growth. Startups rely on their expertise to shorten time to market, identify new revenue streams, and mitigate risks.
By being on the ground where business happens, Business Sweden helps companies seize opportunities and close deals in the world’s most dynamic markets.
Jenny Strömberg
Jenny Strömberg supports Swedish companies in their international expansion through her role at Business Sweden, guiding founders on how to enter and scale in new markets. With a background as a Founder, Investment manager and Business coach, she brings deep startup and growth expertise.
Georg Marthin
Georg Marthin is a Senior Analyst at Business Sweden, responsible for their macroeconomic forecasts. His background spans the Ministry of Finance, National Institute of Economic Research, Swedish Fiscal Policy Council, and Stockholm University’s International Institute of Economic Studies. He helps Swedish companies understand the global macro environment and supports economists, government agencies and institutions in integrating the company perspective into analysis and policy.
Chiaro
Chiaro is a leading European communication agency specializing in strategic storytelling for the health and life sciences sectors. With deep industry expertise, they help companies craft compelling narratives that drive engagement, build trust, and accelerate growth in a competitive global market.
Giuseppe Marzio, Founder Chiaro
Giuseppe Marzio, PhD, is the founder of Chiaro. He has worked with CEOs of leading organizations in the health & life sciences sector, from startups to VCs to large corporations, helping them secure major investments, close high-value deals, and drive success.An Amazon bestselling author and keynote speaker, he champions the power of stories to build a healthier planet.
Smartstep Nordics
SmartStep Nordics supports life science industries in the Nordic and the European markets by providing market access strategies as well as commercially anchored health economics, Health Technology Assessment (HTA) services and real-world-data using solid value- and evidence-based tools and technologies.
Peter Hertzman, CEO and Principal Consultant at SmartStep Nordics
Peter Hertzman, PhLic, has more than 30 years’ experience in various international executive leadership positions in Market Access and Health Economics within the pharmaceutical and biotechnological industry. He has been leading Market Access teams, integrating key access functions in Pricing & Reimbursement, HEOR, Government Affairs, Field Market Access, and Media Advocacy in close collaboration with sales, marketing, medical and R&D. He has been instrumental in securing many successful product launches, for example, within oncology, inflammation, RA, CV/Met, metabolic diseases and medical technologies. This work included direct interactions and negotiations with payer- and HTA-related organizations.
Peter Hertzman holds a research degree (Philosophy Licentiate) in Economics from the University of Lund with focus on Health Economics and is the author of several Health Economics and Market Access publications.
Aistrateg Malmö
Aistrateg Malmö AB is a specialist consultancy in generative AI, helping organisations understand, adopt, and harness the transformative power of this technology. Through executive briefings, hands-on workshops, and continuous trend monitoring, Aistrateg provides leadership teams and boards with both strategic foresight and practical tools. The firm acts as a trusted AI strategy partner to established enterprises and emerging startups alike, with a strong emphasis on building smarter, more efficient workplaces – often within tight resource constraints.
Under the Zello Systems brand, Aistrateg develops AI-powered assistants that allow users to interact with their organisation’s own data in natural language – speeding up access to knowledge and enhancing decision-making across the board.
Dennis Westerberg, Founder & CEO, Aistrateg Malmö
Dennis Westerberg is the founder and CEO of Aistrateg Malmö AB – a respected advisor and in-demand speaker on generative AI among Sweden’s business leaders and public sector executives. With a background as a teacher, entrepreneur and author, Dennis combines technical fluency with strong communication skills and a deep commitment to real-world impact.
His mission is to make AI a practical, everyday tool – not just a technological curiosity. As the driving force behind Zello Systems, he leads the development of AI-driven assistants and serves as a strategic sounding board for executive teams looking to integrate AI into leadership, communication, and decision-making processes.
Secure By Q
Secure By Q empowers organizations to navigate the complexities of modern and digital risks with unmatched consultancy expertise and integrated solutions. Specializing in security, risk management, and compliance, they provide cutting-edge advisory and professional services tailored to both leading enterprises and the public sector.
As a trusted partner in digital security, Secure By Q is not only the consultancy of choice for industry leaders but also a premier destination for top risk and security talent. Their innovative approach ensures organizations stay ahead in an ever-evolving digital landscape.
Janne Karppinen, Director, Secure By Q
Janne Karppinen is a seasoned risk and security advisor with over 20 years of global experience. Janne excels in modern and digital risk management, offering unparalleled expertise across various security domains. His leadership and technical acumen have driven the success of numerous projects in cyber security, travel security, and incident response. Known for his focused, engineer-oriented approach and excellent communication skills, Janne delivers impactful advice to diverse clients. Currently, he advises state agencies, regulated industries, and global tech companies. Janne Karppinen is an inspiring speaker ready to share his wealth of knowledge and experience. Director and co-founder at Secure by Q.
Petter Larsson, Director, Co-Founder, Secure By Q,
Petter Larsson is an advisor in leadership, strategy, and future-ready risk management, security, and compliance, with a robust background in national and international risk and security. Petter’s expertise spans modern and digital risk management, enabling digital transformation, and providing insightful advice drawn from both private and public sectors. His global experience in challenging environments has honed his ability to deliver actionable recommendations and high-level governance insights. Additionally, Petter is a valued strategic coach and a friendly challenger in self-leadership and group development, emphasizing the human element in security. With international board experience, he ensures a strong business- and organization-centered approach to risk and security. Currently, Petter advises on modern and digital risk, cyber and information security, compliance and crisis preparedness, and is a sought-after speaker renowned for his extensive knowledge and inspiring presentations. Director and co-founder at Secure by Q.
Albaeco
Albaeco is a non-profit organisation with expertise in sustainable development and research communication on social-ecological systems, resilience, and transformations in the Anthropocene. Albaeco was part in founding the Stockholm Resilience Centre at Stockholm University in 2007, and has operated for more than 25 years in making research insights applicable to different societal actors, including businesses, government agencies, and educators.
Louise Hård af Segerstad, Co-founder & Co-Director, Albaeco
Louise is co-founder and co-director of Albaeco, and a resilience expert and science communicator. Among other things, she has worked with resilience analysis of municipal food supply and educated many different businesses about what sustainability is in a changing, complex world. Also working for Stockholm Resilience Centre (SRC) as a communications strategist.
Fredrik Moberg, Co-founder & Co-Director, Albaeco
Fredrik is co-founder and co-director of Albaeco. He holds a PhD in coral reef ecology/natural resources management from Stockholm University. He works as director at Albaeco and also as a researcher and senior communications advisor at the Stockholm Resilience Centre. Moberg is a specialist in biodiversity, ecosystem services, and resilience of social-ecological systems, with extensive experience advising companies on sustainable innovation and business strategies.
GBA Key2compliance
GBA Key2Compliance makes complex regulatory processes easier for Medical Device, IVD, and Pharma companies. With over 80 dedicated professionals in Scandinavia and Germany, the company provides expert consulting and specialized training to support businesses in achieving compliance and growth.
As a trusted partner, GBA Key2Compliance prioritizes client success, ensuring a smooth regulatory journey guided by expertise and customer-centric values. As a full-service provider, the company offers expertise in Quality Assurance (QA) for IVD, Medical Devices & Pharma, Regulatory Affairs, Biological Safety, Clinical Development, and Training & Courses. With a strong focus on small and growing companies, GBA Key2Compliance provides tailored solutions to help businesses navigate regulatory challenges with confidence.
Jeanette Demorney
Jeanette Demorney is a Senior Advisor at GBA Key2Compliance with more than 20 years of experience across healthcare, clinical development, medical devices, pharma and CRO environments. She has led clinical strategy from early feasibility through regulatory approval and post-market evidence, working at the intersection of product development, regulatory requirements and commercial decision-making. With a background as a registered nurse and senior leadership roles in MedTech CROs, she is known for translating complex clinical and regulatory demands into clear, value-driven development strategies.
Tomas Camnell
Tomas Camnell is an experienced Quality Manager specializing in medical device production transfers, and global regulatory compliance. His career spans roles at Swedish firms, managing transitions within Sweden, the US, and relocating production to Asia. Tomas excels in securing CE-marking, 510(k) approvals, and listings in Australia, Canada, and Japan. He optimizes QMS to ISO 13485, ISO 9001, and 21 CFR820 standards, implements ISO 14971 risk management, and conducts global audits. He’s a leader in vigilance, post-market surveillance, and regulatory training for medical devices across EU, US, Canada, Australia, and Asia.
SmiLe Venture Hub
SmiLe Venture Hub is a leading venture hub dedicated to supporting life science startups in advancing healthcare. By fostering a dynamic community of passionate innovators, SmiLe provides comprehensive support, including expert coaching, state-of-the-art labs, and access to a global network of industry partners and investors.
Operating on a no-equity basis, SmiLe offers a neutral and independent platform for startups to develop and launch groundbreaking health innovations, ensuring founders retain full control of their ventures while benefiting from world-class resources and mentorship.
Thomas Unt, Deputy CEO of SmiLe Venture Hub and CEO of SmiLe Inject Capital
Thomas Unt is the Deputy CEO of SmiLe Venture Hub and the CEO of SmiLe Inject Capital. With a strong background in finance, life science, retail, entrepreneurship, and innovation, Thomas brings a wealth of expertise to his leadership roles.
He has over 10 years of experience in the financial industry, combined with a proven track record in entrepreneurial development. His experience includes responsibility for venture capital acquisition, IPOs, and corporate structure.
Before joining SmiLe, Thomas served as CEO and COO for multiple startups within the finance and life science sectors, where he honed his skills in driving growth and innovation. His leadership and multi-silo competencies make him a key figure in shaping the future of life science startups and investments.
Magnhild Owman, People and Culture Coach, SmiLe Venture Hub
Magnhild Owman brings expertise in recruitment and organizational development, helping companies build strong leadership foundations and drive sustainable growth. Her experience in global onboarding at Qlik and HR strategy at Web Manuals equips her to guide businesses through rapid expansion and foster high-performance cultures. Magnhild’s strategic approach enhances organizational effectiveness, supporting long-term growth across all business stages.
Åke Bengtsson, Senior Business Advisor, SmiLe Venture Hub
Åke Bengtsson is an entrepreneurial and innovative senior executive with extensive experience as both CFO and CEO. He has a proven track record of developing and transforming international operations within highly competitive industries.With strong analytical skills, Åke excels at identifying emerging trends and opportunities, which he then translates into clear strategies that drive increased shareholder value. His leadership is marked by a focus on growth, transformation, and achieving lasting impact across organizations.
Scaling Life Sciences
Scaling Life Sciences is a growth advisory firm and publishing house supporting life sciences ventures through expert-led workshops, training programs, board and leadership evaluations, and 1:1 leadership advisory. Drawing from insights in Scaling Life Sciences, the company helps scaleups succeed by aligning product, market, and people for sustainable growth.
Martin Stenfeldt, Founder, Scaling Life Sciences
Martin Stenfeldt brings 30 years of global life science experience, spanning 15 years in corporate roles and 15 years in startups and scaleups, including multi-year postings in the US and Germany. An M.Sc. in Business Administration & Economics, he is passionate about venture building, fundraising, commercialization, international expansion, and fostering strong people and culture within life science companies. As the author of Scaling Life Sciences and an award-winning entrepreneur, Martin empowers life science ventures with insights drawn from real-world experience and a commitment to helping life science ventures scale successfully.
Participants
Gasporox
Gasporox is a Lund-based company specializing in laser‑based, non‑destructive gas analysis for quality control in the food, beverage, and pharmaceutical industries. Using TDLAS technology, they develop sensors and instruments that measure headspace gases, verify package integrity, and detect leaks, helping manufacturers ensure safety, accuracy, and compliance.
Read more: https://gasporox.se/
Genovis
Genovis is a life‑science technology company that develops specialized enzymatic tools for researchers and the biopharmaceutical industry. Their enzymes are designed to simplify and accelerate the analysis, modification, and quality control of biological drugs, including antibodies and other complex biologics. Genovis’ solutions are used worldwide to support drug development, diagnostics, and advanced research, helping scientists work more efficiently and with higher precision.
Read more: https://www.genovis.com/
Ironic Biotech
Iron deficiency affects nearly 2 billion people worldwide. Current iron fortification alters taste and quality, while supplements use poorly absorbed inorganic iron with side effects. Ironic Biotech offers an optimal, body-friendly iron for food fortification – without rancidity or metallic taste – helping improve nutrition sustainably as we shift toward plant-based diets.
Read more: https://www.ironicbiotech.com/
Lumito
Lumito is a medical technology company specializing in next‑generation digital tissue imaging. Using upconverting nanoparticles (UCNPs), they provide highly sensitive tools for locating and measuring biomarkers in tissue samples with exceptional clarity and objectivity. Their SCIZYS system enhances research in drug development and digital pathology by delivering precise, high‑contrast images that support more reliable analysis and better-informed scientific insights.
Read more: https://lumito.se/
Redoxis
Redoxis is a CRO and research company with focus on inflammatory conditions. We provide preclinical in vitro and in vivo models for autoimmune and inflammatory diseases, including for example RA, MS and SLE, for efficacy evaluation or investigation of mechanism of action.
Read more: https://www.redoxis.se/
Suturion
Suturion is a medtech company dedicated to support surgeons perform an improved closure of the abdominal wall after open surgery. Our technology does not only increase speed but also improves quality. The result is significantly saved time, reduced risk of infections, burst abdomen and long-term complications like incisional hernia.
Read more: https://www.suturion.com/
Truly Labs
Truly Labs AB is a CRO providing customized in vitro and in vivo services. Our mission is to help our customers to translate preclinical project ideas into efficient experimental plans and conclusive clinical trials. Truly Labs has a team of highly skilled scientists with extensive experience ready to perform customized lab work in our fully equipped labs. All work is characterized by our expertise, experience, commitment, flexibility and high-quality standards.
Read more: https://www.trulytranslational.com/